rsvt vaccine
Vaccineexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
3
Phase 4
0
Earliest trial started Feb 6, 2023 (NCT05687279)
Timeline
Indications
Mechanism of action
- Respiratory syncytial virusImmunity, active
Respiratory syncytial virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06705140 | Phase 3 | Nov 26, 2024 | Sanofi-Aventis |
| NCT06397768 | Phase 3 | May 13, 2024 | Sanofi-Aventis |
| NCT06252285 | Phase 3 | Feb 6, 2024 | Sanofi-Aventis |
| NCT05687279 | Phase 1/Phase 2 (Phase 2) | Feb 6, 2023 | Sanofi-Aventis |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sanofi-Aventis | For profit | 4 | 4 | 2 | 2023 |
1 organizations
Page 1 / 1